Page last updated: 2024-09-03

candoxatrilat and angiotensin ii

candoxatrilat has been researched along with angiotensin ii in 2 studies

Compound Research Comparison

Studies
(candoxatrilat)
Trials
(candoxatrilat)
Recent Studies (post-2010)
(candoxatrilat)
Studies
(angiotensin ii)
Trials
(angiotensin ii)
Recent Studies (post-2010) (angiotensin ii)
4610138,1521,0897,413

Protein Interaction Comparison

ProteinTaxonomycandoxatrilat (IC50)angiotensin ii (IC50)
Atrial natriuretic peptide receptor 3Homo sapiens (human)0.002
Type-1A angiotensin II receptor Rattus norvegicus (Norway rat)0.002
Type-1B angiotensin II receptorRattus norvegicus (Norway rat)0.0018
Type-1 angiotensin II receptorHomo sapiens (human)0.0055
Type-2 angiotensin II receptorRattus norvegicus (Norway rat)0.004
Type-2 angiotensin II receptorHomo sapiens (human)0.0011

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Connell, JM; Cussans, NJ; Davidson, G; Dilly, SG; Doyle, J; Jardine, AG; Leckie, BL; Lever, AF; Northridge, D1
Ferro, CJ; Haynes, WG; Spratt, JC; Webb, DJ1

Trials

2 trial(s) available for candoxatrilat and angiotensin ii

ArticleYear
The atriopeptidase inhibitor UK 69,578 increases atrial natriuretic factor and causes a natriuresis in normal humans.
    American journal of hypertension, 1990, Volume: 3, Issue:9

    Topics: Adult; Aldosterone; Angiotensin II; Atrial Natriuretic Factor; Carbamates; Cyclohexanecarboxylic Acids; Dose-Response Relationship, Drug; Double-Blind Method; Humans; Injections, Intravenous; Kidney; Male; Middle Aged; Natriuresis; Neprilysin; Propionates; Renin; Sodium

1990
Inhibition of neutral endopeptidase causes vasoconstriction of human resistance vessels in vivo.
    Circulation, 1998, Jun-16, Volume: 97, Issue:23

    Topics: Adult; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Atrial Natriuretic Factor; Blood Pressure; Coronary Vessels; Cross-Over Studies; Cyclohexanecarboxylic Acids; Enalapril; Endothelin-1; Humans; Hypertension; Injections, Intra-Arterial; Male; Middle Aged; Myocardium; Neprilysin; Peptides, Cyclic; Protease Inhibitors; Renin; Single-Blind Method; Thiorphan; Vasoconstriction

1998